Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BioLineRx Doses First Patient in Solid Tumor Immunotherapy Study

americanpharmaceuticalreviewSeptember 27, 2019

Tag: BioLineRx , Tumor , AGI-134

PharmaSources Customer Service